Given its neuroprotective potential, GDNF administration has been explored as a therapeutic strategy in preclinical models of PD, where it has been shown to prevent nigral neuron loss and restore disease-associated neurochemical and behavioral changes84,85. Here, GDNF is linked to Parkinson disease.